Ptc Therapeutics, Inc. · NASDAQ:PTCT
Steele Glenn Jr Md Phd sold 12,000 Ptc Therapeutics, Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Steele Glenn Jr Md Phd (Director) sold 12,000 Ptc Therapeutics, Inc. shares at US$65.16 for US$782K under a trading plan, leaving 22,500 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 12,000 shares
- Price
- US$65.16
- Value
- US$782K
- Holding after
- 22,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Option exercise | 12,000 | US$11.23 | 34,500 | Direct |
| Sep 30, 2026 | Common Stock | Sale | 12,000 | US$65.16 | 22,500 | Direct |